Your browser doesn't support javascript.
loading
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Bárcena-Varela, Marina; Caruso, Stefano; Llerena, Susana; Álvarez-Sola, Gloria; Uriarte, Iker; Latasa, M Ujue; Urtasun, Raquel; Rebouissou, Sandra; Alvarez, Laura; Jimenez, Maddalen; Santamaría, Eva; Rodriguez-Ortigosa, Carlos; Mazza, Giuseppe; Rombouts, Krista; San José-Eneriz, Edurne; Rabal, Obdulia; Agirre, Xabier; Iraburu, Maria; Santos-Laso, Alvaro; Banales, Jesus M; Zucman-Rossi, Jessica; Prósper, Felipe; Oyarzabal, Julen; Berasain, Carmen; Ávila, Matías A; Fernández-Barrena, Maite G.
Afiliação
  • Bárcena-Varela M; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Caruso S; Functional Genomics of Solid Tumors, Inserm U1162, Université Paris Descartes, Université Paris Diderot, Université Paris 13, IUH, France.
  • Llerena S; Marqués de Valdecilla University Hospital, Santander, Spain.
  • Álvarez-Sola G; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • Uriarte I; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Latasa MU; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • Urtasun R; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Rebouissou S; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • Alvarez L; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Jimenez M; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Santamaría E; Functional Genomics of Solid Tumors, Inserm U1162, Université Paris Descartes, Université Paris Diderot, Université Paris 13, IUH, France.
  • Rodriguez-Ortigosa C; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Mazza G; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Rombouts K; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • San José-Eneriz E; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, Pamplona, Spain.
  • Rabal O; Hepatology Program, Cima-University of Navarra, Pamplona, Spain.
  • Agirre X; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • Iraburu M; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, Pamplona, Spain.
  • Santos-Laso A; Institute for Liver and Digestive Health, University College London, London, United Kingdom.
  • Banales JM; Institute for Liver and Digestive Health, University College London, London, United Kingdom.
  • Zucman-Rossi J; Oncohematology Program, Cima-University of Navarra, Pamplona, Spain.
  • Prósper F; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, Pamplona, Spain.
  • Oyarzabal J; Molecular Therapeutics Program, Cima-University of Navarra, Pamplona, Spain.
  • Berasain C; Oncohematology Program, Cima-University of Navarra, Pamplona, Spain.
  • Ávila MA; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, Pamplona, Spain.
  • Fernández-Barrena MG; Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain.
Hepatology ; 69(2): 587-603, 2019 02.
Article em En | MEDLINE | ID: mdl-30014490
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Histona-Lisina N-Metiltransferase / Carcinoma Hepatocelular / DNA (Citosina-5-)-Metiltransferase 1 / Neoplasias Hepáticas Experimentais / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Histona-Lisina N-Metiltransferase / Carcinoma Hepatocelular / DNA (Citosina-5-)-Metiltransferase 1 / Neoplasias Hepáticas Experimentais / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha